Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
44.03 USD
-0.18%
Market Closed
Updated:
May 18, 2024
Bristol-Myers Squibb Co
Depreciation & Amortization
|
Bristol-Myers Squibb Co
Depreciation & Amortization Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
$9.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
72%
|
CAGR 10-Years
31%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
$6.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
$3.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Depreciation & Amortization
$497m
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
$1.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Bristol-Myers Squibb Co's Depreciation & Amortization?
Depreciation & Amortization
9.9B
USD
9.9B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Depreciation & Amortization amounts to 9.9B USD.
What is Bristol-Myers Squibb Co's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
31%
31%
Over the last year, the Depreciation & Amortization growth was -3%. The average annual Depreciation & Amortization growth rates for Bristol-Myers Squibb Co have been -2% over the past three years , 72% over the past five years , and 31% over the past ten years .
You don't have any saved screeners yet
